TORONTO (AP) -- TORONTO (AP) -- COSCIENS Biopharma Inc. (CSCI) on Thursday reported a loss of $2.7 million in its second quarter.
On a per-share basis, the Toronto-based company said it had a loss of 85 cents.
The drug developer posted revenue of $2.7 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CSCI at https://www.zacks.com/ap/CSCI
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.